Pharmacoepidemiological and pharmacoeconomic research of the medicines’ usage of peritoneal dialysis in the treatment of the patients with chronic kidney disease
DOI:
https://doi.org/10.24959/sphhcj.15.11Keywords:
medicines for peritoneal dialysis, provision, chronic kidney disease, cost, register wholesale pricesAbstract
In recent years, the number of people has increased who are on peritoneal dialysis (PD), and the age-specific structure of the patients has changed in the direction of increasing elderly patients. In 2013, in Ukraine the proportion of PD in the structure of dialysis therapy was 15.3%. The most number of the patients (43.8%) have been getting PD procedures within 1 to 3 years. The every third patient who receives PD is the villagers. In the structure of supply and availability of PD in the diverse population of regions of Ukraine there are significant differences resulted the organizational and financial nature’s problems. To justify the involvement of additional funding has intended the application of the PD cost per patient for one year. It is established that a significant divergence indicators value depend on the price of the means for PD, the appointment of which depends on the clinical condition of the patient. It is also determined that the least expensive medicine is the usage of the drug «Diavitek PD» (147,606.00 GRN per year), the most expensive is «Dianeal PD 4 with the content of glucose 1,36% m/v/13.6 mg/ml» (679 520, 50 GRN per year).
References
Багдасарова І. В. Хронічна хвороба нирок у дітей та стан замісної ниркової терапії / І. В. Багдасарова, С. П. Фоміна // Український журнал нефрології та діалізу. – 2015. – № 1 (45). – С. 3-7.
Медико-профілактична допомога хворим нефрологічного профілю // М. О. Колесник, Н. О. Сайдакова, Н. І. Козлюк, С. С. Ніколаєнко // Науковий журнал МОЗ України. – 2013. – № 2 (3). – С. 78-87.
Немченко А. С. Дослідження систем реімбурсації (компенсації) вартості лікарських засобів у міжнародній практиці / А. С. Немченко, А. А. Котвіцька // Вісник фармації. – 2007. – № 4. – С. 24-49.
Перитонеальний діаліз в Україні: 2009-2013 / Н. О. Сайдакова, Н. І. Козлюк, С. С. Ніколаєнко, Н. М. Степанова //Український журнал нефрології та діалізу. – 2014. – № 3 (39). – С. 3-14.
Яковлева О. С. Маркетингові дослідження сучасного ринку засобів для перитонеального діалізу / О. С. Яковлева // Технологічнні та біофармацевтичні аспекти створення лікарських препаратів різної направленості дії : матеріали І Міжнар. наук.-практ. Інтернет-конференції. – Х. : НФаУ, 2014. – С. 193-194.
Delphine M. De Smedt. Economic evaluation of different treatment modalities in acute kidney injury / Delphine M. De Smedt, Monique M. Elseviers // Nephrol. Dial. Transplant. – 2012. – Vol. 27. – Р. 4095-4101.
End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) / A. Dor, M. V. Pauly, M. A. Eichleay, P. J. Held // Int. J. Health Care Finance Econ. – 2007. – Vol. 7, № 2-3. – С. 73-111.
Roggeri D. P. Chronic Kidney Disease: Evolution of Healthcare Costs and Resource Consumption from Predialysis to Dialysis in Piedmont Region, Italy [Internet] / D. P. Roggeri [et al.] // Advances in Nephrology. – 2014. – Vol. 2014, Article ID 680737. – 6 p. – Режим доступу: http://www.hindawi.com/journals/an/2014/680737.
United States Renal Data System, 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States / National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases // Am. J Kidney Dis. – 2013. – Vol. 61. – P. 248-258.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
